HomeAPDN • NASDAQ
Applied DNA Sciences Inc
Follow
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 1.20M | 34.28% |
Operating expense | 3.65M | -9.25% |
Net income | -2.64M | -138.84% |
Net profit margin | -220.57 | -77.86% |
Earnings per share | -28.08 | 89.82% |
EBITDA | -2.91M | 16.75% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 9.29M | 176.70% |
Total assets | 15.97M | 61.11% |
Total liabilities | 3.42M | -40.86% |
Total equity | 12.55M | — |
Shares outstanding | 1.10M | — |
Price to book | 0.12 | — |
Return on assets | -51.53% | — |
Return on capital | -64.82% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -2.64M | -138.84% |
Cash from operations | -3.33M | 11.49% |
Cash from investing | -116.88K | — |
Cash from financing | 6.31M | 18,078.74% |
Net change in cash | 2.86M | 175.49% |
Free cash flow | -2.27M | -0.76% |
Previous close
$1.45
Day range
$1.10 - $1.27
Year range
$1.10 - $430.00
Market cap
1.36M USD
Avg Volume
1.97M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1983
Website
Employees
47